The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 05, 2010

Filed:

Nov. 28, 2007
Applicants:

Gerd Bartoszyk, Weiterstadt, DE;

Christoph Seyfried, Seeheim, DE;

Christoph Von Amsterdam, Darmstadt, DE;

Henning Boettcher, Darmstadt, DE;

Ewen Sedman, Alresford, GB;

Inventors:

Gerd Bartoszyk, Weiterstadt, DE;

Christoph Seyfried, Seeheim, DE;

Christoph Von Amsterdam, Darmstadt, DE;

Henning Boettcher, Darmstadt, DE;

Ewen Sedman, Alresford, GB;

Assignee:

Merck Patent GmbH, Darmstadt, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/497 (2006.01);
U.S. Cl.
CPC ...
Abstract

1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine or a physiologically acceptable salt thereof is used for the manufacture of a medicament for the treatment of sub-type anxiety disorders chosen from the sub-types panic disorder with or without agoraphobia, agoraphobia obsessive-compulsive spectrum disorders, social phobia, posttraumatic stress disorder, acute stress indication or generalized-anxiety disorder, bipolar disorders, mania, dementia substance-related disorders, sexual dysfunctions, eating disorders, obesity, anorexia and fibromyalgia. A preferred salt is 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride.


Find Patent Forward Citations

Loading…